Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.


Afghanistan says Pakistan strikes kill and injure dozens
Police officer killed, dozens injured in bomb explosions in Ukraine's Lviv
Trump pivots to new 15% global tariff after Supreme Court setback
Hong Kong plans to buy homes devastated in deadly high-rise fire
US Supreme Court strikes down Trump's global tariffs
